Loiasis: Clinical Trials

2 trials for Loiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 1, Unknown 1
Phase 21Unknown 1

Follow Loiasis: new trials by email Literature Review of Loiasis trials Research Report on Loiasis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia
Albendazole 400mg, Placebo - Loiasis With Positive Blood Microfilaremia, Loiasis
Phase 3Not yet recruitingProgramme National de Lutte contre l'Onchocercose, Republic of the Congo1002025-01-152024-09-26
A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects
Levamisole 3 days, Levamisole 5 days, Placebo - Loiasis
Phase 2 / Phase 3UnknownProgramme National de Lutte contre l'Onchocercose, Republic of the Congo992024-06-212024-09-20

Narrower conditions

Filariasis (2)  ·  Onchocerciasis (2)

Broader conditions

Helminthiasis (2)  ·  Infections (2)  ·  Nematode Infections (2)  ·  Parasitic Diseases (2)  ·  Secernentea Infections (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)  ·  Skin Diseases, Parasitic (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Spirurida Infections (2)

Interventions

Albendazole (1)  ·  Levamisole (1)

Sponsors

Programme National de Lutte contre l'Onchocercose, Republic of the Congo (2)

Countries

Republic of the Congo (1)

Results publications

PMID 40615414